These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 2731977)

  • 41. Intranasal administration of recombinant Neisseria gonorrhoeae transferrin binding proteins A and B conjugated to the cholera toxin B subunit induces systemic and vaginal antibodies in mice.
    Price GA; Russell MW; Cornelissen CN
    Infect Immun; 2005 Jul; 73(7):3945-53. PubMed ID: 15972481
    [TBL] [Abstract][Full Text] [Related]  

  • 42. IgA isotype restriction in the mucosal but not in the extramucosal immune response after oral immunizations with cholera toxin or cholera B subunit.
    Lycke N; Lindholm L; Holmgren J
    Int Arch Allergy Appl Immunol; 1983; 72(2):119-27. PubMed ID: 6874106
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Construction and preclinical evaluation of recombinant Peru-15 expressing high levels of the cholera toxin B subunit as a vaccine against enterotoxigenic Escherichia coli.
    Roland KL; Cloninger C; Kochi SK; Thomas LJ; Tinge SA; Rouskey C; Killeen KP
    Vaccine; 2007 Dec; 25(51):8574-84. PubMed ID: 18045752
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Heterologous antigen expression in Vibrio cholerae vector strains.
    Butterton JR; Beattie DT; Gardel CL; Carroll PA; Hyman T; Killeen KP; Mekalanos JJ; Calderwood SB
    Infect Immun; 1995 Jul; 63(7):2689-96. PubMed ID: 7790086
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Frequent nasal administrations of recombinant cholera toxin B subunit (rCTB)-containing tetanus and diphtheria toxoid vaccines induced antigen-specific serum and mucosal immune responses in the presence of anti-rCTB antibodies.
    Yasuda Y; Isaka M; Taniguchi T; Zhao Y; Matano K; Matsui H; Morokuma K; Maeyama J; Ohkuma K; Goto N; Tochikubo K
    Vaccine; 2003 Jun; 21(21-22):2954-63. PubMed ID: 12798639
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Distribution, persistence, and recall of serum and salivary antibody responses to peroral immunization with protein antigen I/II of Streptococcus mutans coupled to the cholera toxin B subunit.
    Russell MW; Wu HY
    Infect Immun; 1991 Nov; 59(11):4061-70. PubMed ID: 1937766
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Local and systemic antibody responses and immunological memory in humans after immunization with cholera B subunit by different routes.
    Svennerholm AM; Gothefors L; Sack DA; Bardhan PK; Holmgren J
    Bull World Health Organ; 1984; 62(6):909-18. PubMed ID: 6335849
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Intestinal and systemic immune responses to an oral cholera toxoid B subunit whole-cell vaccine administered during zinc supplementation.
    Karlsen TH; Sommerfelt H; Klomstad S; Andersen PK; Strand TA; Ulvik RJ; Ahrén C; Grewal HM
    Infect Immun; 2003 Jul; 71(7):3909-13. PubMed ID: 12819076
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Mucosal and systemic antibody responses against an acellular pertussis vaccine in mice after intranasal co-administration with recombinant cholera toxin B subunit as an adjuvant.
    Isaka M; Yasuda Y; Taniguchi T; Kozuka S; Matano K; Maeyama J; Morokuma K; Ohkuma K; Goto N; Tochikubo K
    Vaccine; 2003 Mar; 21(11-12):1165-73. PubMed ID: 12559794
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Antigenicity of cholera toxoid in humans.
    Germanier R; Fürer E; Varallyay S; Inderbitzin TM
    J Infect Dis; 1977 Apr; 135(4):512-6. PubMed ID: 856918
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Secondary Vibrio cholerae-specific cellular antibody responses following wild-type homologous challenge in people vaccinated with CVD 103-HgR live oral cholera vaccine: changes with time and lack of correlation with protection.
    Losonsky GA; Tacket CO; Wasserman SS; Kaper JB; Levine MM
    Infect Immun; 1993 Feb; 61(2):729-33. PubMed ID: 8423098
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Local production of anti-vibrio cholerae mucosal antibody in reproductive tract tissues after cholera.
    Ryan ET; Bridges EA; Crean TI; Gausia K; Hamadani JD; Aziz A; Hawkes S; Begum M; Bogaerts J; Faruque SM; Salam MA; Fuchs GJ; Calderwood SB
    J Infect Dis; 2001 Sep; 184(5):643-7. PubMed ID: 11494170
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Systemic and mucosal immune responses of mice to aluminium-adsorbed or aluminium-non-adsorbed tetanus toxoid administered intranasally with recombinant cholera toxin B subunit.
    Isaka M; Yasuda Y; Kozuka S; Miura Y; Taniguchi T; Matano K; Goto N; Tochikubo K
    Vaccine; 1998 Oct; 16(17):1620-6. PubMed ID: 9713937
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Rotavirus virus-like particles administered mucosally induce protective immunity.
    O'Neal CM; Crawford SE; Estes MK; Conner ME
    J Virol; 1997 Nov; 71(11):8707-17. PubMed ID: 9343229
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Five-year immunologic memory in Swedish volunteers after oral cholera vaccination.
    Jertborn M; Svennerholm AM; Holmgren J
    J Infect Dis; 1988 Feb; 157(2):374-7. PubMed ID: 3335813
    [No Abstract]   [Full Text] [Related]  

  • 56. Protective efficacy in humans of killed whole-vibrio oral cholera vaccine with and without the B subunit of cholera toxin.
    Black RE; Levine MM; Clements ML; Young CR; Svennerholm AM; Holmgren J
    Infect Immun; 1987 May; 55(5):1116-20. PubMed ID: 3552989
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Oral administration of cholera toxin-Sendai virus conjugate potentiates gut and respiratory immunity against Sendai virus.
    Liang XP; Lamm ME; Nedrud JG
    J Immunol; 1988 Sep; 141(5):1495-501. PubMed ID: 2842395
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Salivary, nasal, genital, and systemic antibody responses in monkeys immunized intranasally with a bacterial protein antigen and the Cholera toxin B subunit.
    Russell MW; Moldoveanu Z; White PL; Sibert GJ; Mestecky J; Michalek S M
    Infect Immun; 1996 Apr; 64(4):1272-83. PubMed ID: 8606090
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Antitoxic immunity in experimental cholera: protection, and serum and local antibody responses in rabbits after enteral and parenteral immunization.
    Holmgren J; Svennerholm AM; Ouchterlony O; Anderson A; Walletström G; Westerberg-Berndtsson U
    Infect Immun; 1975 Dec; 12(6):1331-40. PubMed ID: 54337
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Expression and secretion of cholera toxin B subunit in lactobacilli.
    Okuno T; Kashige N; Satho T; Irie K; Hiramatsu Y; Sharmin T; Fukumitsu Y; Uyeda S; Yamada S; Harakuni T; Miyata T; Arakawa T; Imoto M; Toda A; Nakashima Y; Miake F
    Biol Pharm Bull; 2013; 36(6):952-8. PubMed ID: 23727916
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.